Alumis Inc (ALMS)

Alumis Inc (ALMS) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $885M; returns 1 day -0.6%, 1 week +10.8%, 1 year +47.1%.

Alumis Inc. (ALMS) is a clinical-stage biopharmaceutical company based in South San Francisco, California, dedicated to developing next-generation targeted oral therapies for immune-mediated diseases. The company's business model is centered on the research and development of novel small-molecule drugs, with clinical trials conducted through external sites.

Groups ALMS belongs to

• Biotechnology
• Biopharmaceutical
• Clinical Stage Biotech
• Clinical Stage Biopharma
• Clinical Stage
• Autoimmune Diseases
• Dermatology
• Healthcare
• Life Sciences
• R&D

ALMS financial model: income statement, cash flow and balance sheet